Skip to main content
Premium Trial:

Request an Annual Quote

BioArchitect, GeneMap, Virtek ChipWriter Pro, Virtek ChipReader.

Premium

Bio-Aware of Chaumont-Gistoux, Belgium has launched BioArchitect, a new bioinformatics software for designing microarrays. The software allows users to configure common parameters such as the direction of the pumping, the number of pins, the slide or membrane orientation, the direction of arraying, and size of spots. It also shows a preview of the arrays with its graphical tool. Using this tool, researchers can highlight or color specific spots, as well as import and export microplates. The data is stored in an MS-Access 2000 database.

A demo of the software is available for downloading on the Bio-Aware website, www.bio-aware.com.

Genomic Solutions of Ann Arbor, Mich., has augmented its microarray portfolio with a new collection of GeneMap cytokine arrays for human, mouse, and rat genomes. The cDNA arrays include cDNA probes for chemokines, cytokines, and receptors.

Genomic Solutions also offers pre-printed rat genome, mouse genome, and human cancer arrays, as part of its all-in-one GeneTac automated biochip system.

Virtek Vision, of Waterloo, Ontario, has placed its Virtek ChipWriter Pro microarray spotter and Virtek ChipReader microarray scanner in chemical engineering departments at the University of California Los Angeles and the Massachusetts Institute of Technology for use in microarray research.

UCLA professor James Liao will use both pieces of Virtek equipment in a course on microarray technology for industrial scientists, statisticians, engineers, chemists, and physicists.

At MIT, researchers working under professor Charles Cooney are using the Virtek ChipWriter and ChipReader to work on recombinant protein production. In professor Gregory Stephanopoulos’ lab, these instruments are being used to study genetic and metabolic changes in diseases such as diabetes, and metabolic processes in bacteria.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.